Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 07, 2013
The Scientific and Regulatory Consulting business of Cardinal Health Specialty Solutions (Beckloff Associates) will provide regulatory support to the National Institutes of Health’s (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program ...
read more
Thursday, September 30, 2021
Care Access, the world’s leading decentralized research organization (DRO), announced its expanded partnership with global biopharma leader Eli Lilly and Company (Lilly) to broaden patient access to clinical trials and increase representation of ...
read more
Caris Life Sciences® announced it has acquired Pharmatech, a developer of the original Just-In-Time research system with the largest research-ready oncology network.
read more
Wednesday, August 27, 2014
Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, ...
read more
Thursday, November 15, 2012
Catalent Pharma Solutions today announced that it had reached a commercial cell line sales agreement with CEVEC Pharmaceuticals for recombinant human alpha-1 antitrypsin (hAAT).
read more
Thursday, January 08, 2015
Catalent Announces the Appointment of Two Industry Leaders to Support Growth in its Clinical Supply Services European Network
read more
Tuesday, October 07, 2014
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced two appointments to the management structure of its Development and ...
read more
Wednesday, April 17, 2013
Catalent Pharma Solutions today announced that it has made two senior appointments to support its recently established joint ventures in China for its Softgel Technologies and Clinical Supply Solutions (CSS) businesses. Dr. Weiyan “Jackson” Zhu has ...
read more
Friday, February 17, 2012
Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the...
read more
Friday, December 02, 2022
Catalent announced that it has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
read more
Monday, November 01, 2021
Catalent, a global leader in clinical supply services, today announced the opening of a new facility in San Diego, in response to increased demand from pharmaceutical and biopharmaceutical customers for integrated development, clinical packaging, and...
read more
Thursday, December 12, 2019
Catalent announced the launch of its new CTSuccess™ clinical trial planning service.
read more
Thursday, October 07, 2021
Catalent, a global leader in clinical supply services, today announced the opening of its new clinical supply facility, strategically located in the Shiga prefecture of Japan, in response to increased demand for end-to-end services, including primary...
read more
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more
Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, and Adamas Pharmaceuticals Inc., today announced an agreement for Phase 3 clinical trials ...
read more